📰 Malini Chatterjee News
Malini Chatterjee News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Malini Chatterjee. Real-time updates on events, politics, business and more.
January 3, 2024
SOUTH SAN FRANCISCO, Calif., Jan. 03, 2024 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology”) (Nasdaq: ALXO), a clinical-stage immuno-oncology company developing therapies that block the CD47 checkpoint pathway,
October 3, 2023
-- Evorpacept is the first CD47 blocker to show activity in a global randomized study in solid tumors
September 13, 2023
BRISBANE, Australia & MINNEAPOLIS--(BUSINESS WIRE)--Anteris Technologies Ltd (Anteris or the Company) (ASX: AVR), a structural heart company developing the world’s only balloon-expandable, single-piece transcatheter aortic valve (TAVR) for the treatment of aortic stenosis announced today that Wayne Paterson, the Chi...
September 12, 2023
BRISBANE, Australia & MINNEAPOLIS--(BUSINESS WIRE)--Anteris Technologies Ltd (Anteris or the Company) (ASX: AVR), a structural heart company developing the world’s only balloon-expandable,
August 31, 2023
SOUTH SAN FRANCISCO, Calif., Aug. 31, 2023 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., ("ALX Oncology") (NASDAQ:ALXO), a clinical-stage immuno-oncology company developing therapies that block the CD47 checkpoint
August 14, 2023
BRISBANE, Australia & MINNEAPOLIS--(BUSINESS WIRE)--Anteris Technologies Ltd (Anteris or the Company) (ASX: AVR, OTC: ANTTY) reported today that DurAVR™ THV, a new class of biomimetic heart valve and
July 31, 2023
BRISBANE, Australia & MINNEAPOLIS, July 31, 2023--Anteris Technologies Ltd, (Anteris or the Company) (ASX: AVR), a structural heart company developing DurAVR™ THV, a new class of biomimetic heart valve and the world’s only balloon-expandable, single-piece transcatheter aortic valve shaped to mimic the performance of a native human aortic valve, announces that the DurAVR™ THV was used for the first time in a valve-in-valve (ViV) procedure as part of Health Canada’...